A unique set of complex chromosomal abnormalities in an infant with myeloid leukemia associated with Down syndrome-Reference-Cited by-同舟云学术

A unique set of complex chromosomal abnormalities in an infant with myeloid leukemia associated with Down syndrome

Published:2017-09-11 Issue:1 Volume:10 Page:
ISSN:1755-8166
Container-title:Molecular Cytogenetics
language:en
Short-container-title:Mol Cytogenet

Author:

de Souza Daiane Correa,de Figueiredo Amanda Faria,Ney Garcia Daniela R.,da Costa Elaine Sobral,Othman Moneeb A.K.,Liehr Thomas,Abdelhay Eliana,Silva Maria Luiza Macedo,de Souza Fernandez Teresa

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry, medical,Genetics(clinical),Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Link

http://link.springer.com/content/pdf/10.1186/s13039-017-0335-3.pdf

Reference22 articles.

1. Forestier E, Izraeli S, Beverloo B, Haas O, Pession A, Michalová K, Stark B, Harrison CJ, Teigler-Schlegel A, Johansson B. Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study. Blood. 2008;111:1575–83.

2. Hasle H, Niemeyer CM, Baumann I, Bennett JM, Kerndrup G, Head DRA. Pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia. 2003;17:277–82.

3. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–405.

4. Klusmann JH, Creutzig U, Zimmermann M, Dworzak M, Jorch N, Langebrake C, Pekrun A, Macakova-Reinhardt K, Reinhardt D. Treatment and prognostic impact of transient leukemia in neonates with Down syndrome. Blood. 2008;111:2991–8.

5. Blink M, Zimmermann M, von Neuhoff C, Reinhardt D, de Haas V, Hasle H, O'Brien MM, Stark B, Tandonnet J, Pession A, Tousovska K, Cheuk DK, Kudo K, Taga T, Rubnitz JE, Haltrich I, Balwierz W, Pieters R, Johansson B, van den Heuvel-Eibrink MM, Zwaan CM. Normal karyotype is a poor prognostic factor in myeloid leukemia of Down syndrome: a retrospective, international study. Haematologica. 2014;99:299–307.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in molecular characterization of myeloid proliferations associated with Down syndrome;Frontiers in Genetics;2022-08-10

2. Systematics for types and effects of DNA variations;BMC Genomics;2018-12

3. Down syndrome associated childhood myeloid leukemia with yet unreported acquired chromosomal abnormalities and a new potential adverse marker: dup(1)(q25q44);Molecular Cytogenetics;2018-03-13